Home/ News & Events
This year, the annual meeting of the Inborn Errors Working Party (IEWP) will be happening in Paris, France, September 23-25th 2022 as a face-to-face event.
The deadline for applications for the ESID Junior Talent Award 2022 is extended to 15th of July 2022!
Find all the information you need about how to apply for ESID Junior Talent Award 2022 available exclusively to ESID junior members!
We are pleased to announce that the Call for candidates for the ESID Junior Country Representatives (2022-2024) is now open.
ESID registry Working Party is inviting the ESID registry participants to take part in the "Malignancies in IEI" study latest by August 31st 2022.
The IDDA score has already been available as optional module (tab) in the level 1 for your own use at the initial and follow up patient entries and is designed for all IEI with immune dysregulation. Now, I am inviting your active contribution to a prospective study until end of 2023 (prolongation possible), aiming to implement a powerful tool for assessment and monitoring of disease activity and phenotype patterns!
Since the start of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, there has been rapid progress with understanding disease, clinical phenotypes and biology, improving treatment and implementing vaccination trials. Data is accumulating about the impact of COVID-19 for patients with Inborn Errors of Immunity (IEI). The purpose of this statement is to summarise our state of knowledge and set out ESID’s current guidance for professionals in the IEI community in Europe. We will update this statement as evidence emerges.
ESID is profoundly concerned about the grave repercussions of the conflict in Ukraine on PID community, healthcare and patients.
Together with IPOPI, INGID and J Project stakeholders, we have released a statement of solidarity and support to those impacted by the war in Ukraine.
Call for international contributions relating to IPEX patients infected with SARS-CoV-2.